Proton pump inhibitors drastically modify triosephosphate isomerase from Giardia lamblia at functional and structural levels, providing molecular leads in the design of new antigiardiasic drugs
详细信息    查看全文
文摘

Proton pump inhibitors (PPIs) are extensively used in clinical practice because of their effectiveness and safety in humans.

The glycolytic enzyme triosephosphate isomerase from Giardia lamblia (GlTIM) is a good target to generate antigiardiasic drugs.

All the proton pump inhibitors efficiently inactivate and desestabilizate the GlTIM at functional and structural levels.

Rabeprazole represents a promising lead in the search of new antigiardiasic drugs.

The mechanisms of action of the PPIs on GlTIM can be helpful to understand their effectiveness and safety in human.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700